SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-20-073826
Filing Date
2020-06-16
Accepted
2020-06-16 17:12:07
Documents
8
Effectiveness Date
2020-06-16

Document Format Files

Seq Description Document Type Size
1 FORM S-8 tm2022591-1_s8.htm S-8 65177
2 EXHIBIT 4.7 tm2022591d1_ex4-7.htm EX-4.7 10140
3 EXHIBIT 4.8 tm2022591d1_ex4-8.htm EX-4.8 154780
4 EXHIBIT 5.1 tm2022591d1_ex5-1.htm EX-5.1 7006
5 EXHIBIT 23.1 tm2022591d1_ex23-1.htm EX-23.1 2204
6 EXHIBIT 23.2 tm2022591d1_ex23-2.htm EX-23.2 2534
7 GRAPHIC tm2022591d1_ex4-7img01.jpg GRAPHIC 110919
8 GRAPHIC tm2022591d1_ex4-7img02.jpg GRAPHIC 261367
  Complete submission text file 0001104659-20-073826.txt   735283
Mailing Address 50 TICE BLVD, SUITE A26 WOODCLIFF LAKE NJ 07677
Business Address 50 TICE BLVD, SUITE A26 WOODCLIFF LAKE NJ 07677 973-314-9570
Timber Pharmaceuticals, Inc. (Filer) CIK: 0001504167 (see all company filings)

IRS No.: 593843182 | State of Incorp.: DE | Fiscal Year End: 0131
Type: S-8 | Act: 33 | File No.: 333-239216 | Film No.: 20967248
SIC: 2834 Pharmaceutical Preparations